Toshihiko Iwamoto

Learn More
BACKGROUND AND PURPOSE The progression of cognitive deterioration in patients with Alzheimer's disease (AD) is considerably variable. The ability to predict the progression rate is important for(More)
BACKGROUND/AIMS A 24-week, randomized, parallel-group, double-blind placebo-controlled study was conducted to evaluate the efficacy and tolerability of donepezil in severe Alzheimer's disease (AD).(More)
DISCUSSION Vitamin D is a safe, inexpensive strategy to reduce falls and associated medical costs. This study showed that older fallers have a low rate of meeting the vitamin D RAI, especially men,(More)